Replies to post #400247 on Elite Pharmaceuticals Inc (ELTP)

[ARbigguy1]

NAS, yes you are correct, that was global.
From Elite's PR on FDA acceptance - $42 million
April 20, 2023 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP), a specialty pharmaceutical company developing niche generic products, today announced that it filed an Abbreviated New Drug Application (ANDA) with the US Food and Drug Administration (FDA) for an undisclosed generic drug product in a class of medications called antimetabolites. IQVIA reported annual sales for the twelve months ending December 2022 of $42 million for the generic market for this product.